UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 9,411	$ 8,633
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	452	461
Amortization	1,714	1,898
Provision for (recovery of) losses on accounts receivable	0	(9)
(Gain) loss on disposal of assets	5	1
Deferred income taxes	(351)	(359)
Stock-based compensation expense	62	66
Changes in operating assets and liabilities:
Accounts receivable - trade	(510)	(791)
Accrued interest and other receivables	(35)	(83)
Inventories	(222)	151
Prepaid expenses and other current assets	36	76
Accounts payable	316	31
Accrued expenses	228	(180)
Total adjustments	1,695	1,262
Net cash provided by operating activities	11,106	9,895
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(237)	(151)
Capital expenditures for intangible assets	(9)	(55)
Net cash provided by (used in) investing activities	(246)	(206)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	306	298
Common stock purchased and retired	0	(683)
Payment of taxes for exchange of stock options	0	(42)
Tax benefit attributable to exercise of stock options	37	110
Repayment of notes payable	0	(4,778)
Payment of dividends	(1,954)	(1,914)
Net cash provided by (used in) financing activities	(1,611)	(7,009)
Effect of exchange rate changes on cash	(971)	(332)
Net increase in cash and cash equivalents	8,278	2,348
Cash at beginning of period	23,278	19,274
Cash at end of period	31,556	21,622
Cash paid during the period for income taxes	3,342	4,030
Cash paid during the period for interest	$ 0	$ 65